-
GCTB sparse shrunk LD matrices from 2.8M common variants from the UK Biobank ...
GCTB sparse shrunk LD matrices from 2.8M common variants from the UK Biobank. Part AC of AA, AB, AC, AD and AE -
GCTB sparse shrunk LD matrices from 2.8M common variants from the UK Biobank ...
GCTB sparse shrunk LD matrices from 2.8M common variants from the UK Biobank. Part AD of AA, AB, AC, AD and AE -
Participant Demographics.
1Age at enrolment,2mean value (range),3Body Mass Index,4Pre-enrolment IgA anti-tissue transglutaminase (normal range below 20 U/ml),5duration of... -
dedup_wf_001--52d323398de494c75c4c5b7809b9bd98
Poster presented at 'Alzheimer's Association International Conference (AAIC)'; 16th-20th July 2017; London, UK. -
Summary statistics.
Values are presented as Mean ±SEM. Abbreviations: fWHR [34]; EME [44]; ULh, LLh and Nw [33]; Index 1 [47], Index 2 [48], [50], Index 3 [10], [49], ProcDist [54], [79], DiscSco1... -
Study characteristics.
*other than SAA: MAA or not reported degree of severity. †other than first-line MRD: second-line HSCT, first-line mismatched related HSCT, first-line- unrelated HSCT.‡Fouladi... -
Characteristics of included studies.
RCT: Randomised controlled trial. GS: Gilead Sciences. R: Roche. GSK: GlaxoSmithKline. NS: not stated. aCopies/mL converted to IU/mL by dividing by 5.bThe limit of detection of...
